Platelet-rich-plasma Treating Tennis Elbow

Use of Platelet-rich-plasma to Treat Tennis Elbow, A Blinded and Randomized Single Center Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00757289

Enrollment

106

Registered

2008-09-23

Start date

2007-08-31

Completion date

2009-01-31

Last updated

2017-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Tennis Elbow

Brief summary

The study is to compare the efficacy of autologous platelet concentrate injections to corticosteroid injection in patients suffering from tennis elbow with respect to pain and function.

Detailed description

Patients with chronic plantar fasciitis will be allocated randomly to have a steroid injection or an autologous platelet concentrate injections. Data will be collected before the procedure, 4, 8, 12, 26 weeks and 1 year after the procedure. The main outcome measures of this study are pain and function measured with questionnaires.

Interventions

BIOLOGICALPRP Injection

PRP Injection

BIOLOGICALCorticosteroid Injection

Corticosteroid Injection

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient with chronic epicondylitis lateralis who do not react to conservative treatment and therefore are send to the orthopedic surgeon

Design outcomes

Primary

Measure	Time frame
Visual Analog Score - Pain	4months,12 months,24months & 52 months

Secondary

Measure	Time frame
DASH	4months,12months,24months & 52 months
Complications	Anytime

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026